Issue 110 • September 2021

Inside the AUD drug pipeline

Can mRNA revolutionise flu jabs?

Tackling pharmaceutical pollution

In association with

Once more unto the (data) breach

Pharma has become a hot target for cybercriminals over recent years, but what can companies learn from previous hacking attempts?

In association with

02/23/2024 22:30:22
  • Home | Once more unto the (data) breach
  • In this issue
  • Contents
  • SHL Medical
  • SHL Medical Company Insight
  • Datwyler Company Insight
  • Datwyler
  • Labcorp
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • Baxter
  • Sukano Company Insight
  • Sukano
  • Comment
  • Use of off-label therapies increases the need for reliable clinical trial data
  • Unmet needs remain in the neuroendocrine tumour treatment paradigm
  • Drinking alcohol raises risk of oesophageal and other cancers
  • Verder Company Insight
  • Verder
  • RegPak
  • Avery Dennison
  • In Depth
  • Pharma cybersecurity breaches to know and learn from
  • The drugs treating alcoholism
  • In with the old: how an established vaccine is fuelling Covid-19 treatment
  • How are hospitals tackling pharmaceutical pollution?
  • After Covid-19, mRNA technology aims to revolutionise the flu shot
  • Pushing for a UK genomics revolution
  • Micronova
  • Pfeiffer Vacuum
  • HOF Sonderanlagenbau
  • In Data
  • Data: pharma subsidiaries
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
08/19/2021 00:00:00